The President’s Emergency Plan for AIDS Relief (PEPFAR), a US global HIV response program credited with saving millions of lives, has been reauthorized until March 25, 2025, with the passage of an omnibus funding bill. The bill, which does not include any controversial changes linked to abortion debates, offers a short-term reprieve for PEPFAR. However, this is a marked departure from the program’s past, and future elections could have significant implications for PEPFAR’s trajectory and funding.
StockWatch: uniQure Shares Reach Five-Year High on “Game Changing” Huntington’s Data
The dazzling 36-month clinical data announced by uniQure (NASDAQ: QURE) showing a significant slowing of Huntington’s disease (HD) progression in patients treated with its gene
